SCM
REGN icon

SKBA Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

SKBA Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1M Hold
1,295
– – 0.14% 59
2025
Q4 		$1,000K Sell
1,295
-3
-0.2% -$2.04K 0.14% 63
2025
Q3 		$730K Buy
1,298
+100
+8% +$56.5K 0.1% 69
2025
Q2 		$629K Buy
1,198
+221
+23% +$123K 0.09% 67
2025
Q1 		$620K Buy
977
+237
+32% +$163K 0.09% 66
2024
Q4 		$527K Hold
740
– – 0.08% 64
2024
Q3 		$778K Hold
740
– – 0.12% 60
2024
Q2 		$778K Sell
740
-15
-2% -$14.5K 0.12% 61
2024
Q1 		$727K Buy
755
+5
+0.7% +$4.75K 0.11% 59
2023
Q4 		$659K Sell
750
-45
-6% -$37.1K 0.11% 58
2023
Q3 		$654K Hold
795
– – 0.12% 57
2023
Q2 		$571K Hold
795
– – 0.1% 59
2023
Q1 		$653K Sell
795
-50
-6% -$37.7K 0.12% 57
2022
Q4 		$610K Hold
845
– – 0.11% 56
2022
Q3 		$582K Hold
845
– – 0.12% 54
2022
Q2 		$500K Hold
845
– – 0.1% 56
2022
Q1 		$590K Hold
845
– – 0.11% 55
2021
Q4 		$534K Hold
845
– – 0.1% 58
2021
Q3 		$511K Hold
845
– – 0.1% 59
2021
Q2 		$472K Buy
845
+100
+13% +$50.7K 0.09% 61
2021
Q1 		$352K Buy
745
+145
+24% +$70.6K 0.06% 66
2020
Q4 		$290K Buy
600
+10
+2% +$5.4K 0.05% 66
2020
Q3 		$330K Sell
590
-40
-6% -$24.3K 0.07% 62
2020
Q2 		$393K Sell
630
-70
-10% -$39.7K 0.08% 56
2020
Q1 		$342K Hold
700
– – 0.08% 56
2019
Q4 		$263K Buy
+700
New +$236K 0.04% 69

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SKBA Capital Management's REGN Position: Q1 2026 in Review

SKBA Capital Management held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 1,295 shares worth $1M. The position accounts for 0.14% of the portfolio, ranked #59.

SKBA Capital Management first reported a position in REGN in Q4 2019 and has held it in 26 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • SKBA Capital Management held 1,295 shares of Regeneron Pharmaceuticals worth $1M as of Q1 2026.
  • SKBA Capital Management left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.14% of SKBA Capital Management's portfolio in Q1 2026, its #59 holding.
  • SKBA Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 26 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on SKBA Capital Management's 13F filing for Q1 2026, filed 13 May 2026.